COPD and CBD

COPD

More than 15.3 million Americans suffer from COPD, a disease that often leads to a lowered quality of life and shortened lifespan. Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung condition ranging from mild to severe and characterized by difficulty breathing and restricted airflow into and out of the lungs. COPD is an umbrella term encompassing chronic bronchitis and/or emphysema. Without the proper intake of oxygen, the rest of your body suffers. It becomes difficult to physically exert yourself and, eventually, to perform simple tasks like walking. Additionally, COPD causes high blood pressure and leads to heart disease. Because COPD is a progressive disease, these problems grow worse over time.

 

Two studies done in 2014 and 2015 have shown that CBD can help open breathing passages and make breathing easier for those suffering from COPD. Additionally, CBD has been shown to reduce the inflammation and lung damage caused by COPD. 

 

Experts suggest 1-6mg of CBD per ten pounds of body weight daily to begin COPD dosage. Keep a journal of your symptoms to track your success and find the right dose for you. Pinene is an excellent bronchodilator: look for strains high in this terpene. 

 

Due to the nature of the illness, it is recommended not to smoke or vape your CBD.


Always check with your medical provider before discontinuing any medications.

 

Product Recommendations

 

Flower - Flower should be used to make edibles rather than smoke. High pinene strains would be ideal.

 

All of our CBD drops are effective at reducing inflammation. Most customers take between 10 – 30 mg per day.

 

All Edibles - Lolo’s Gummies and Cereal Bars are a great way to intake CBD!


References

“CBD and Lung Disease: Lung Health Institute.” Lung Health Instititute, 21 Feb. 2020, lunginstitute.com/blog/can-cbd-cure-my-lung-disease/

“CBD Oil for COPD: How to Use This Cannabinoid Oil & Dosage.” CFAH, 11 July 2020, www.cfah.org/cbd-oil-for-copd/

Makwana, Raj, et al. “The Effect of Phytocannabinoids on Airway Hyper-Responsiveness, Airway Inflammation, and Cough.” Journal of Pharmacology and Experimental Therapeutics, American Society for Pharmacology and Experimental Therapeutics, 1 Apr. 2015, jpet.aspetjournals.org/content/353/1/169


Leave a comment

Please note, comments must be approved before they are published